News
DRIO
12.05
+1.69%
0.20
DarioHealth’s digital health platform shows blood pressure improvements
TipRanks · 1d ago
DarioHealth Publishes Peer-Reviewed Study Titled "The Impact of Digital Intervention Messages Targeting Users With High Blood Pressure Events: Retrospective Real-World Study," In JMIR Cardio.
Benzinga · 1d ago
Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio
PR Newswire · 1d ago
DarioHealth announces 79 new accounts signed year-to-date
TipRanks · 3d ago
DarioHealth Signs 79 New Employer Clients in 2025
Reuters · 3d ago
DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date
PR Newswire · 3d ago
Weekly Report: what happened at DRIO last week (1124-1128)?
Weekly Report · 4d ago
DarioHealth Announces The Publication Of A New Peer-Reviewed Study In The Journal Of Medical Internet Research Showing Digital Diabetes Platform Cuts Hospitalizations 23% And Healthcare Costs 26% Vs. Usual Care
Benzinga · 11/24 13:12
DarioHealth announces publication of study in JMIR on digital health platform
TipRanks · 11/24 13:10
DarioHealth Digital Platform Cuts Hospitalization Rates and Healthcare Costs, Peer-Reviewed Study Finds
Reuters · 11/24 13:01
DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year
PR Newswire · 11/24 13:00
Weekly Report: what happened at DRIO last week (1117-1121)?
Weekly Report · 11/24 10:05
Weekly Report: what happened at DRIO last week (1110-1114)?
Weekly Report · 11/17 10:05
DarioHealth price target raised to $11 from 60c at TD Cowen
TipRanks · 11/14 13:50
DarioHealth price target lowered to $16 at Stifel after reverse stock split
TipRanks · 11/14 12:30
Stifel Nicolaus Remains a Buy on DarioHealth (DRIO)
TipRanks · 11/14 12:26
U.S. RESEARCH ROUNDUP-Disney, Enanta Pharmaceuticals, Phillips 66
Reuters · 11/14 09:48
DARIOHEALTH CORP <DRIO.O>: TD COWEN RAISES TARGET PRICE TO $11 FROM $0.60
Reuters · 11/14 04:54
DarioHealth Reports Q3 2025 Financial Results
TipRanks · 11/14 04:29
DarioHealth’s Earnings Call: Optimism Amid Revenue Shift
TipRanks · 11/14 00:38
More
Webull provides a variety of real-time DRIO stock news. You can receive the latest news about Dariohealth Corp through multiple platforms. This information may help you make smarter investment decisions.
About DRIO
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.